NM

Newtyn Management Portfolio holdings

AUM $660M
This Quarter Return
+12.81%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$660M
AUM Growth
+$660M
Cap. Flow
+$14.2M
Cap. Flow %
2.15%
Top 10 Hldgs %
67.45%
Holding
40
New
9
Increased
8
Reduced
8
Closed
6

Sector Composition

1 Healthcare 28.7%
2 Real Estate 17.14%
3 Consumer Discretionary 15.18%
4 Communication Services 10.22%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ITOS
26
DELISTED
iTeos Therapeutics
ITOS
$5.66M 0.86%
+567,416
New +$5.66M
RCKT icon
27
Rocket Pharmaceuticals
RCKT
$355M
$4.9M 0.74%
+2,000,000
New +$4.9M
MITK icon
28
Mitek Systems
MITK
$448M
$4.8M 0.73%
484,954
-236,600
-33% -$2.34M
KROS icon
29
Keros Therapeutics
KROS
$648M
$3.3M 0.5%
+246,857
New +$3.3M
ABEO icon
30
Abeona Therapeutics
ABEO
$359M
$2.73M 0.41%
480,000
WVE icon
31
Wave Life Sciences
WVE
$1.25B
$2.6M 0.39%
400,000
AVIR icon
32
Atea Pharmaceuticals
AVIR
$271M
$2.09M 0.32%
580,000
ETNB icon
33
89bio
ETNB
$1.39B
$1.96M 0.3%
200,000
MURA icon
34
Mural Oncology
MURA
$36M
$1.41M 0.21%
570,000
CLFD icon
35
Clearfield
CLFD
$441M
-300,000
Closed -$8.92M
GLPG icon
36
Galapagos
GLPG
$2.05B
-200,000
Closed -$5.02M
THRD
37
DELISTED
Third Harmonic Bio
THRD
-635,150
Closed -$2.2M
TSVT
38
DELISTED
2seventy bio
TSVT
-2,534,836
Closed -$12.5M
VTOL icon
39
Bristow Group
VTOL
$1.07B
-18,080
Closed -$571K
USAR
40
USA Rare Earth, Inc. Class A Common Stock
USAR
$1.37B
-692,650
Closed -$7.62M